Doxorubicin-loaded hollow gold nanospheres for dual photothermal ablation and chemoembolization therapy

Rahul A. Sheth,Xiaoxia Wen,Junjie Li,Marites P. Melancon,Xin Ji,Y. Andrew Wang,Cheng-Hui Hsiao,Diana S.-L. Chow,Elizabeth M. Whitley,Chun Li,Sanjay Gupta

DOI: https://doi.org/10.1186/s12645-020-00062-8

2020-07-01

Cancer Nanotechnology

Abstract:Doxorubicin-loaded hollow gold nanospheres (Dox@HAuNS) are a promising technology for simultaneous trans-arterial tumor-targeted chemotherapy delivery and thermal ablation. We evaluated the efficacy of intra-arterial delivery of Dox@HAuNS followed by photothermal ablation (PTA) in a rabbit model of liver cancer. Adult New Zealand white rabbits (<i>N</i> = 25) were inoculated with VX2 tumors into the left lobe of the liver. The animals were then randomized to sham surgery (<i>N</i> = 5), PTA only (<i>N</i> = 3), Dox@HAuNS only (<i>N</i> = 5), HAuNS + PTA (<i>N</i> = 5), and Dox@HAuNS + PTA (<i>N</i> = 7). Nanoparticles were delivered as an emulsion with Lipiodol (Guerbet, France) via a trans-arterial approach. Following nanoparticle delivery, PTA was performed using an 808-nm fibered laser at 1.5 W for 3 min. Thermography during PTA demonstrated a sustained elevation in tumoral temperature in both HAuNS + laser and Dox@HAuNS + laser treatment groups relative to animals that underwent laser treatment without prior nanoparticle delivery.

nanoscience & nanotechnology,oncology